What is he best known for?
The fields of study he is best known for:
- Virus
- Internal medicine
- Hepatitis C virus
His scientific interests lie mostly in Virology, Hepatitis C virus, Immunology, Hepacivirus and Virus.
Harel Dahari is involved in the study of Virology that focuses on Viral replication in particular.
He has included themes like Daclatasvir and NS5A in his Viral replication study.
His Hepatitis C virus research integrates issues from Interferon and Viral load.
His Viral load research incorporates elements of Internal medicine, Danoprevir, Hepatitis c viral and Polymerase chain reaction.
His Hepacivirus study incorporates themes from Telaprevir and Drug resistance.
His most cited work include:
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy (1910 citations)
- Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus (308 citations)
- Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life (253 citations)
What are the main themes of his work throughout his whole career to date?
Harel Dahari spends much of his time researching Virology, Hepatitis C virus, Internal medicine, Virus and Hepatitis C.
His Viral replication, Hepatitis B virus, Interferon and HBsAg study in the realm of Virology connects with subjects such as Kinetics.
Hepatitis C virus is frequently linked to Viral load in his study.
He combines subjects such as Gastroenterology and Sofosbuvir with his study of Internal medicine.
His study in the fields of Titer under the domain of Virus overlaps with other disciplines such as Lonafarnib.
His research in Hepatitis C intersects with topics in Liver disease, Hcv elimination and Incidence.
He most often published in these fields:
- Virology (82.35%)
- Hepatitis C virus (75.16%)
- Internal medicine (41.83%)
What were the highlights of his more recent work (between 2018-2021)?
- Virology (82.35%)
- Hepatitis C (37.91%)
- Hepatitis C virus (75.16%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Virology, Hepatitis C, Hepatitis C virus, Internal medicine and Hepatitis B virus.
His work on HBsAg, Hepatitis D virus and Hepatitis B as part of general Virology research is frequently linked to Chemistry and Mode of action, thereby connecting diverse disciplines of science.
His research integrates issues of Hcv elimination, Incidence and Virological response in his study of Hepatitis C.
Hepatitis C virus is a subfield of Virus that he tackles.
The Internal medicine study combines topics in areas such as Gastroenterology, Ribavirin, Sofosbuvir and Viral load.
His study in Hepatitis B virus is interdisciplinary in nature, drawing from both Acquired immune system, Interferon, Pegylated interferon and Intracellular.
Between 2018 and 2021, his most popular works were:
- Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study (16 citations)
- Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis. (9 citations)
- Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg. (8 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Hepatitis C
Harel Dahari mostly deals with Internal medicine, Hepatitis C, Hepatitis C virus, Gastroenterology and Viral load.
The concepts of his Hepatitis C study are interwoven with issues in Hcv transmission, Incidence and Environmental health.
His Hepatitis C virus research includes elements of Treatment duration and Vaccination.
His Gastroenterology study combines topics in areas such as Solid organ transplantation, Response to therapy, Baseline level, Virological response and Antihistamine.
His research in Viral load tackles topics such as Liver disease which are related to areas like Organ transplantation, Transplantation, Hepatitis B virus and Cirrhosis.
His Antiviral therapy study is concerned with Virology in general.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
